Brandinium

Trademark search for:

RELIEF THERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-08-03 — Application filed
  • 2016-12-22 — Sn assigned for sect 66a appl from ib
  • 2016-12-23 — Assigned to examiner
  • 2016-12-23 — Application filed
  • 2016-12-27 — Application filed
  • 2016-12-28 — Final disposition recorded
  • 2016-12-29 — Office action issued
  • 2017-01-10 — Office action issued
  • 2017-01-10 — Office action issued
  • 2017-01-27 — Office action issued
  • 2017-07-10 — Office action issued
  • 2017-07-10 — Correspondence received in law office
  • 2017-07-11 — Teas/email correspondence entered
  • 2017-07-14 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-07-14 — Attorney/dom.rep.revoked and/or appointed
  • 2017-08-01 — Final disposition recorded
  • 2017-08-01 — Final disposition recorded
  • 2017-08-01 — Final disposition recorded
  • 2018-02-01 — Office action issued
  • 2018-02-01 — Correspondence received in law office
  • 2018-02-02 — Teas/email correspondence entered
  • 2018-02-22 — Examiners amendment -written
  • 2018-02-22 — Examiners amendment e-mailed
  • 2018-02-22 — Notification of examiners amendment e-mailed
  • 2018-02-22 — Examiner's amendment entered
  • 2018-03-15 — Approved for pub - principal register
  • 2018-03-15 — New representative at ib received
  • 2018-03-28 — Notice of start of opposition period created, to be sent to ib
  • 2018-03-28 — Notification of notice of publication e-mailed
  • 2018-03-28 — Notification of possible opposition sent to ib
  • 2018-04-13 — Notification processed by ib
  • 2018-04-17 — Published for opposition
  • 2018-04-17 — Official gazette publication confirmation e-mailed
  • 2018-05-23 — Notification of possible opposition created, to be sent to ib
  • 2018-05-23 — Notification of possible opposition sent to ib
  • 2018-06-08 — Notification of possible opposition - processed by ib
  • 2018-07-03 — Registered-principal register
  • 2018-10-03 — Final disposition recorded
  • 2018-10-05 — Final disposition recorded
  • 2018-10-05 — Final disposition recorded
  • 2018-10-26 — Final disposition recorded
  • 2022-01-20 — Teas withdrawal as domestic representative received
  • 2022-01-20 — Applicant/correspondence changes (non-responsive) entered
  • 2022-01-20 — Teas change of owner address received
  • 2022-01-20 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-01-20 — Attorney/dom.rep.revoked and/or appointed
  • 2022-01-20 — Teas change of correspondence received
  • 2022-02-18 — New representative at ib received
  • 2022-03-22 — Teas section 7 request received
  • 2022-04-16 — Change of name/address rec'd from ib
  • 2022-08-16 — Case assigned to post registration paralegal
  • 2022-08-24 — Post registration action mailed - sec. 7
  • 2023-07-03 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2024-06-01 — Application abandoned
  • 2025-01-17 — Cancelled section 71
  • 2025-01-17 — Final status recorded
  • 2025-09-17 — Total invalidation of reg ext protection created

Owner Information

Relief Therapeutics Holding S.A.
CH
Relief Therapeutics S.A.
Genève CH
Relief Therapeutics S.A.
Genève CH

Correspondent

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C
1100 New York Avenue, NW
Washington, DC 20005
UNITED STATES

Filing Details

Filing Date:
2016-08-03
Status Date:
2025-01-17
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.